研究者業績

加藤 賢一

kato kenichi

基本情報

所属
藤田保健衛生大学 医学部 医学科 リウマチ・感染症内科学 講師
学位
博士(医学)

J-GLOBAL ID
200901062559954350
researchmap会員ID
5000024679

MISC

 6
  • Tomoko Otake, Mutsumi Ashihara, Jo Nishino, Kenichi Kato, Shusaku Fukaya, Shunji Yoshida
    RHEUMATOLOGY INTERNATIONAL 33(4) 887-891 2013年4月  査読有り
    The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, "What do you feel is your strongest stressor?" The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.
  • 加藤賢一, 金森里美, 太田美幸, 平野大介, 岩破由実, 登坂信子, 小野田覚, 西野譲, 深谷修作, 吉田俊治
    日本内科学会雑誌 101 305-305 2012年  
  • 西野譲, 野嵜美幸, 平野大介, 岩破由実, 岩舘知史, 小野田覚, 登坂信子, 加藤賢一, 深谷修作, 吉田俊治
    日本内科学会雑誌 100 198-198 2011年  
  • Kenichi Kato, Satoru Onoda, Junichiro Asano, Shusaku Fukaya, Shunji Yoshida
    MODERN RHEUMATOLOGY 20(4) 366-369 2010年8月  査読有り
    Serum (1 -> 3)-beta-d-glucan levels and clinical findings were evaluated in 229 inpatients with connective tissue diseases (CTDs) during the period between June and October 2004. The mean serum (1 -> 3)-beta-d-glucan level was 129.7 +/- A 207.6 pg/mL in patients with a definitive diagnosis of fungal infections and 10.5 +/- A 8.6 pg/mL in patients without fungal infections. Analysis of the diagnostic sensitivity/specificity for various (1 -> 3)-beta-d-glucan cutoff levels gave the best results for a cutoff level of 15 pg/mL, with a sensitivity of 92.3% and specificity of 81.3%. This level was therefore determined to be the optimal cutoff in patients with CTDs.
  • 西野譲, 岩館知史, 小野田覚, 登坂信子, 大竹智子, 浅野純一郎, 加藤賢一, 水谷昭衛, 深谷修作, 吉田俊治
    日本内科学雑誌 99 201 2010年  
  • 西野譲, 加藤賢一, 吉田秀雄, 片山雅夫, 深谷修作, 吉田俊治
    日本臨床免疫学会雑誌 32(1) 61-65 2009年  査読有り

講演・口頭発表等

 44

その他教育活動上特記すべき事項

 4
  • 件名
    医学教育ワークショップ
    終了年月日
    2008/06/06
    概要
    「PBLテュータ・トレーニング」に参加
  • 件名
    医学教育ワークショップ
    終了年月日
    2010/11/08
    概要
    「PBLテュータ・トレーニング」に参加
  • 件名
    医学教育ワークショップ
    終了年月日
    2014/05/17
    概要
    「PBLテュータ・トレーニング」に参加
  • 件名
    医学教育ワークショップ
    終了年月日
    2014/06/07
    概要
    「PBLテュータ・トレーニング」に参加